Entegris Ventures

Our portfolio boasts over 300 active patents covering world-changing innovations. We back the teams we believe are best able to deploy revolutionary technologies. We have board representation at over 80% of our portfolio companies. We're committed to working alongside our founders to commercialize scientific discovery. Our portfolio companies have collectively raised over two billion dollars. We invest across the life cycle of a company from pre-seed to pre-IPO. Our Name The name, Fine Structure Ventures®, is perhaps most meaningful to the scientist-entrepreneurs we partner with. In physics, the fine-structure constant, commonly denoted by α (the Greek letter alpha), is named for the spacing between the spectral lines in the fine structure of the hydrogen atom. It is a dimensionless, fundamental physical constant which describes the interaction between elementary charged particles, such as electrons, and an electromagnetic field. If the value of alpha were much different from the one we know, it would impact whether nuclear fusion within stars produces carbon or whether atoms can form stable molecules–both of which are critical for life. The fine structure constant is moreover the single best predicted constant in all of physics. Quantum electrodynamics, a field founded by Julian Schwinger, Richard Feynman, and Freeman Dyson, predict its value from first principles, and the associated experiments match to 11 digits. At Fine Structure Ventures, we are also making predictions to realize alpha, used in this context to represent excess return on investment. We take a first principles approach, looking for technologies that, if realized at scale, would have obvious, dramatic, global impact. While we only aspire to the brilliance of Dyson or Feynman, we nevertheless seek unprecedented accuracy in our evaluation of investment opportunities. A Rich Legacy Fine Structure Ventures is rooted in one of America’s great entrepreneurial success stories. Fidelity Investments was founded in 1946 and grew from a single mutual fund into one of the largest asset management firms in the world, with over $2 trillion under management. For the last fifty years, our independent venture capital group has had the privilege of backing other great entrepreneurs as they built ground-breaking companies, including Atari and MCI in the early days. A Focused Team of Specialists Although we are backed by a resourceful global platform, we are a small team passionate about the impact science can make and singularly focused on the success of the entrepreneurs we are privileged to work with. We bring together decades of experience in investments, operations, entrepreneurship, and in scientific research.

MANN+HUMMEL is a leading global company in filtration technology. Under its two business units Transportation and Life Sciences & Environment, the Ludwigsburg-based Group develops intelligent solutions that enable cleaner mobility, cleaner air and cleaner water. Thus, the company makes an important contribution to a clean earth and the sustainable use of limited resources. In 2020, over 21,000 employees at more than 80 locations generated a turnover of EUR 3.8 billion. Among the solutions are filter media and simulation technologies, liquid filters, air filtration and intake systems for various mobility and industrial applications, and membrane technologies for municipal and industrial water and wastewater treatment and use in sensitive process applications such as food manufacturing or biotechnology. Furthermore, the family-owned company founded in 1941 offers air and molecular filtration technologies for building filtration as well as for industrial applications and cleanrooms. These are used, for example, in power generation, microelectronics or operating rooms. Stationary and mobile air purifiers for indoor, semi-open spaces and outdoor areas complete the holistic approach to clean air. Depending on the area of application, they filter viruses, free allergens, bacteria or fine dust and nitrogen oxides from the ambient air.

We look for companies in Italy and selectively abroad. 5 KEY SECTORS Founded in 2016, today Indaco Venture Partners SGR is the largest independent Italian venture capital asset management company, with a strong specialization in companies that innovate in electronics, robotics and new materials, medtech, biotech – pharma and digital. EXPERIENCE The investment team managers have an extensive experience in venture investing in Italy and abroad and have executed a high number of successful exits, including IPOs and transactions with corporate partners.

We partner early with unstoppable entrepreneurs leveraging breakthrough science and technology to pursue progress at scale. Everything we do revolves around a single problem: What are the best ways to reconcile economic growth with human and planetary health? We invest in teams and solutions that address multi-decade problems that humanity has no choice but to solve. Our focusing questionsHow can we decouple improving living standards from resource depletion? How can we ensure food, energy and materials supply security when confronted by deglobalization, multipolarity and the distractions of the attention economy? How can we improve life on Earth and unlock future economic growth potential by leveraging next-generation computing and exploring outer space? How can the clean industrialization of biological processes reduce humanity’s impact on our planet? How we invest in unstoppable founders We look to problems and unmet needs first and then to which technologies and solutions have the potential to address those problems effectively. We don’t push any one type of technology or limit ourselves to one field. We look for founders and companies at the pre-seed and seed stages leveraging the three basic disciplines (physics, chemistry, biology) to engineer economically viable solutions. We look for teams that are uniquely suited to address the opportunity and its inherent challenges and for solutions that are radically better, technically viable, and defensible. Some of the areas we are keen to continue exploring include clean commodities, space technology, industrial decarbonization, electro- and green chemistry, next-generation computing, new materials & production methods. How we partner for the long-term Starlight is a Pre-Seed and Seed investor and ideally the first institutional check into your company. Having been in your shoes as founders and scientists ourselves, we will serve as an ally in the journey ahead. Here’s what you can expect from working with us: We will lead or co-lead your first institutional round. We reserve capital for follow-on investment in later rounds, and we have to ability to partner with our LPs to augment our participation in future opportunities. We will be personally invested in your success, as a large portion of our fund comes from our own team. We will put a particular focus on ensuring that your roadmap is focused on the key risks and milestones unique to addressing the most pressing problems. We will work with you to establish rock-solid governance and operational practices that hold up to the scrutiny of the world’s best institutional investors. We will help you line up and credibly engage the right future investors for your business and trajectory. Let’s partner and make change happen.

Labena Ventures empowers CEE startups to scale globally. We take high-potential startup ventures on a fast-paced learning journey to help them explore and access business opportunities. Through highly-customized programmes, mentoring dedicated experts, as well as access to our vast network of business partners and investors, we help startups from all stages and across various industries on their way to international success. Labena Ventures, program aimed at scouting the most promising innovative startups and emerging companies throughout the Biotech, Pharma and Health value chains.

The ZEISS Group is a technology and innovation leader in the fields of optics, optoelectronics and precision engineering and in the respective applications. Its core strategic business units operate in attractive target markets with long-term growth prospects that are supported by megatrends. These megatrends open up significant new business opportunities relevant for ZEISS, especially along Horizon Two and Three for future growth. To address these opportunities, ZEISS Ventures, a unit within the ZEISS Group, makes investments and actively manages a portfolio of startup companies. We focus on opportunities that are between, beyond, or disruptive to the core strategic business units of the ZEISS Group. Our goal is to invest in and partner with startup companies to build lasting and sustainable businesses.